0001127602-17-017360.txt : 20170509
0001127602-17-017360.hdr.sgml : 20170509
20170509153330
ACCESSION NUMBER: 0001127602-17-017360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170426
FILED AS OF DATE: 20170509
DATE AS OF CHANGE: 20170509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edge Therapeutics, Inc.
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leuthner Brian A
CENTRAL INDEX KEY: 0001652973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 17826134
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1600
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-04-26
0001472091
Edge Therapeutics, Inc.
EDGE
0001652973
Leuthner Brian A
300 CONNELL DRIVE,
SUITE 4000
BERKELEY HEIGHTS
NJ
07922
1
1
President and CEO
Common Stock
2017-04-26
4
S
0
100
11.10
D
135236
D
Common Stock
162000
I
By Spouse
Common Stock
223622
I
By Trust
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed as an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed as an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ Albert N. Marchio II, attorney-in-fact
2017-05-09